Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 2
2006 4
2007 2
2008 1
2009 1
2010 5
2011 2
2012 1
2014 2
2015 2
2016 4
2017 1
2018 2
2020 2
2021 2
2022 1
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Together we can counter the effects of climate change.
Adrian G, Dietrich M, Esser B, Hensel A, Isermeyer F, Messner D, Mettenleiter TC, Paulini I, Riewenherm S, Schaade L, Tiesler R, Wieler LH. Adrian G, et al. Among authors: dietrich m. J Health Monit. 2023 Jun 1;8(Suppl 3):3-5. doi: 10.25646/11399. eCollection 2023 Jun. J Health Monit. 2023. PMID: 37342427 Free PMC article. No abstract available.
[Frequently asked questions (FAQ) in risk communication about COVID-19: creation and significance as an inter-institutional rapid reaction tool].
Seefeld L, Frentz F, Horstkötter N, Peter C, Dietrich M. Seefeld L, et al. Among authors: dietrich m. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 May;65(5):577-588. doi: 10.1007/s00103-022-03532-z. Epub 2022 Apr 13. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022. PMID: 35419640 Free PMC article. Review. German.
Lrp1 in osteoblasts controls osteoclast activity and protects against osteoporosis by limiting PDGF-RANKL signaling.
Bartelt A, Behler-Janbeck F, Beil FT, Koehne T, Müller B, Schmidt T, Heine M, Ochs L, Yilmaz T, Dietrich M, Tuckermann JP, Amling M, Herz J, Schinke T, Heeren J, Niemeier A. Bartelt A, et al. Among authors: dietrich m. Bone Res. 2018 Feb 26;6:4. doi: 10.1038/s41413-017-0006-3. eCollection 2018. Bone Res. 2018. PMID: 29507818 Free PMC article.
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer.
Gerber DE, Socinski MA, Neal JW, Wakelee HA, Shirai K, Sequist LV, Rosovsky RP, Lilenbaum RC, Bastos BR, Huang C, Johnson ML, Hesketh PJ, Subramaniam DS, Dietrich MF, Chai F, Wang Y, Kazakin J, Schwartz B, Schiller JH, Brahmer JR, Kelly RJ. Gerber DE, et al. Among authors: dietrich mf. Lung Cancer. 2018 Mar;117:44-49. doi: 10.1016/j.lungcan.2018.01.010. Epub 2018 Feb 3. Lung Cancer. 2018. PMID: 29496255 Free PMC article. Clinical Trial.
38 results